Life Sciences Expo 2018 Press Release

Share on Social Media

A Showcase and Catalyst for Continued Ecosystem Growth in RI and Southeastern New England

Get all the Expo details on the event website:

PROVIDENCE, RI: MedMates, Rhode Island’s life sciences BIO affiliate, is pleased to announce the official program for its second annual Life Sciences Expo being held on Wednesday April 4, 2018, from 9:00 am – 6:00 pm at the Omni Providence Hotel, 1 West Exchange Street, Providence, RI.

“Our mission is to grow the local life science economy by bringing together and advocating for talent and resources to support the life sciences community in southeastern New England,” said Carol Malysz, executive director of MedMates. “This event is designed to enhance the connectivity between the life science entities in the region, and to showcase the truly remarkable innovation that is happening here.”

Susan Windham Bannister, PhD, President & CEO of Biomedical Growth Strategies will be the keynote speaker. A world-renowned innovator, Susan formerly served as the founding President & CEO of the Massachusetts Life Sciences Center, overseeing a $1 billion investment to accelerate the pace of growth in pharmaceuticals, biotechnology, medical devices, medical diagnostics and bioinformatics.

Robert Coughlin, President & CEO of MassBio, will close the day by moderating a panel discussion on the Vision for Innovation in Rhode Island. Before joining MassBio, Bob served as the Undersecretary of Economic Development with Governor Deval Patrick’s administration, where he was a strong advocate for the life science industry in Massachusetts.

The Expo program includes panel discussions on industry-wide issues such as investment, innovation and growing the supply chain and industry ecosystem locally, and also includes specific life science topics such as immuno-oncology and CAR-T cell therapies, Alzheimer’s disease and health technology innovation.

Leading life science researchers, clinicians, and executives representing Novartis, Johnson & Johnson, MassBio, Wexford, and Sorrento Therapeutics will join local experts from the Warren Alpert Medical School, Boston University School of Medicine, Rhode Island Hospital, Roger Williams Medical Center, Slater Technology Fund, Cherrystone Angel Group and the University of Rhode Island. A dedicated zone supporting start-ups with drop-in advice clinics, as well as an expanded exhibitor hall, have been added to this year’s event, as well as an evening reception and lunch to facilitate more peer-to-peer contact and networking.

Sponsors to date include Biotechnology International Organization (BIO), Virgin Pulse, Amgen, Aspiera Medical, New England Medical Innovation Center and Medley Genomics. For further information on sponsorship opportunities, please contact Donald Frugé at [email protected].

About MedMates

MedMates is Rhode Island’s life sciences industry network group dedicated to galvanizing collaboration between life sciences companies, hospitals, universities, sources of capital and governmental partners. Our mission is to grow the life sciences economy in RI. We do this by attracting, bringing together and advocating for talent and resources to support the life sciences community throughout southeastern New England. Founded in 2013, MedMates members have deep experience in the fast-changing life sciences fields, ranging from startups to mature companies and everything in between. For more information, visit

For additional information, contact: Carol Malysz at [email protected] or 401-400-5499.

Download the pdf of this press release here.

Latest News

HPNE Launches Initiative to Hire 150+ Employees by Q1 of 2022

HPNE Launches Initiative to Hire 150+ Employees by Q1 of 2022

Smithfield, RI – High Purity New England, a supplier of solutions and equipment for the biopharmaceutical industry, is undergoing a substantial hiring push – looking to immediately begin hiring more than 150+ employees by Q1 2022. Over the past few years alone,...

Amgen Releases 8th Edition of Biosimilar Trends Report

Amgen Releases 8th Edition of Biosimilar Trends Report

Report Finds That Competition Created by Biosimilars Delivered $9.8 Billion in Savings Over the Past Five Years to the U.S. Healthcare System, Generating Savings for Patients, Payers and EmployersWith Both a Strong Innovator Portfolio and a Deep Investment in...

Biotech Industry News